Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 1,568,841 | 1,568,841 | 0 | $66.03M | $82.52M | 23.84% | +$16.49M |
| GH Research PLC(GHRS) | 6,443,940 | 6,746,951 | +303,011 | $71.08M | $82.25M | 23.76% | +$11.17M |
| Stoke Therapeutics, Inc.(STOK) | 5,291,929 | 5,404,674 | +112,745 | $35.19M | $61.34M | 17.72% | +$26.15M |
| Protagonist Therapeutics Inc | 733,014 | 733,014 | 0 | $35.45M | $40.51M | 11.70% | +$5.07M |
| Cullinan Therapeutics, Inc.(CGEM) | 3,215,722 | 4,400,842 | +1,185,120 | $24.34M | $33.14M | 9.57% | +$8.80M |
| Allogene Therapeutics Inc | 11,057,009 | 11,057,009 | 0 | $16.14M | $12.49M | 3.61% | -$3.65M |
| TScan Therapeutics, Inc.(TCRX) | 5,357,347 | 7,857,347 | +2,500,000 | $7.39M | $11.39M | 3.29% | +$4.00M |
| C4 Therapeutics, Inc.(CCCC) | 7,098,133 | 7,098,133 | 0 | $11.36M | $10.15M | 2.93% | -$1.21M |
| Precision BioSciences, Inc.(DTIL) | 766,051 | 1,036,051 | +270,000 | $3.65M | $4.35M | 1.26% | +$697.4K |
| Passage Bio, Inc.(PASG) | 9,256,953 | 9,256,953 | 0 | $3.27M | $3.71M | 1.07% | +$436.9K |
| Upstream Bio, Inc.(UPB) | 219,247 | 219,247 | 0 | $1.34M | $2.41M | 0.70% | +$1.07M |
| iBio, Inc.(IBIO) | 862,279 | 1,538,573 | +676,294 | $3.47M | $1.17M | 0.34% | -$2.29M |
| Neuphoria Therapeutics Inc | 45,806 | 45,806 | 0 | $263.8K | $325.2K | 0.09% | +$61.4K |
| Design Therapeutics, Inc.(DSGN) | 65,954 | 65,954 | 0 | $254.6K | $222.3K | 0.06% | -$32.3K |
| Assembly Biosciences Inc | 0 | 10,366 | +10,366 | $0 | $187.8K | 0.05% | +$187.8K |